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Keratinocytes represent the main constituents of the
epidermis and have been found to play a regulatory
role in a variety of in¯ammatory skin diseases. The
functional activity of keratinocytes is highly hetero-
geneous, and depends on the cell localization in the
epidermal architecture, and the maturation or differ-
entiation state of the cells. Spontaneously proliferat-
ing HaCaT cells, showing several similarities to basal
epidermal keratinocytes, were found to respond to
external chemoattractants, including the chemokines
RANTES (regulated on activation normal T cell
expressed and secreted) and interleukin-8 and the m-
opioid agonist DAMGO ([d-ala2, N-Me-Phe4, Gly-
ol5]enkephalin) in migration assays. The chemotactic
responsiveness was highly dependent on the cell
density of the monolayer, with greatest chemotactic
activity at the highest cell density. Whereas RANTES
was found to be the most potent chemoattractant,
constitutive RANTES production was also detected
in the HaCaT cultures. We found an inverse correl-
ation between constitutive RANTES production
and chemotactic responsiveness toward external
RANTES, suggesting a possible functional down-
modulation of the RANTES receptors, CC chemo-
kine receptor 1 and CC chemokine receptor 5,
during culture. Results from confocal laser scanning
microscopy showed reduced CC chemokine receptor
1, but not CC chemokine receptor 5, expression by
HaCaT cells at low cell densities, which was abol-
ished in the presence of neutralizing antibodies
against RANTES. The total CC chemokine receptor
1 pool (surface and intracellular receptors), however,
showed no signi®cant change during in vitro culture.
Chemotactic responsiveness toward RANTES was
directly correlated with the level of CC chemokine
receptor 1 surface expression. Taken together these
results show that with keratinocyte proliferation and
the progressive increase in cell density there are dra-
matic alterations in keratinocyte function. Key words:
CCR1/chemokine/HaCaT/migration/opioid. J Invest
Dermatol 117:1083±1090, 2001
K
eratinocytes represent the most numerous con-
stituents of the epidermis, which is composed of
several well-de®ned layers with distinct morpho-
logic and functional characteristics. The most active
cells are located in the basal layer, and are
responsible for the continuous regeneration of epidermis via
mitotic cell division. In certain conditions these basal keratinocytes
produce a number of biologically active substances, including
interleukins (Castells-Rodellas et al, 1992; Hammerberg et al, 1998;
KaÈmpfer et al, 1999; Naderi et al, 1999; Naik et al, 1999; RuÈckert
et al, 2000), chemokines (Nakamura et al, 1995; Boorsma et al,
1998; Engelhardt et al, 1998; Fukuoka et al, 1998; Brzoska et al,
1999; Raychaudhuri et al, 1999; Albanesi et al, 2000; Frank et al,
2000; Rennekampff et al, 2000; Wetzler et al, 2000), and opioids
(Mazurkiewicz et al, 2000; Wintzen et al, 1996; Zanello et al, 1999),
and migrate (Ando and Jensen, 1993; Engelhardt et al, 1998;
MaÈkelaÈ et al, 1999; Gibbs et al, 2000) on the wound bed during the
reepithelialization process of wound healing. Immunohistologic
analysis of in¯amed skin samples provides strong evidence for a
pathognomic role of chemokines in recruitment of leukocytes into
the epidermis. Activated keratinocytes have been found to express
surface receptors for cytokines (Grewe et al, 1996; Groves et al,
1996), chemokines (Tuschil et al, 1992; Schulz et al, 1993;
Devalaraja et al, 2000), and opioids (Nissen and Kragballe, 1997;
Bigliardi et al, 1998; Bigliardi-Qi et al, 2000); however, the
functional role of these receptors is not completely understood.
The HaCaT immortalized human keratinocyte cell line exhibits
several similarities to primary basal keratinocytes. These cells are
able to proliferate in serum-supplemented media without addition
of growth factors, and in certain culture conditions generate skin
equivalents (Boelsma et al, 1999; Schoop et al, 1999). In tissue
culture, proliferating keratinocytes form a con¯uent monolayer on
adhesive surfaces, and although reaching the maximum cell density
stage in abundant nutritional conditions the proliferation activity
gradually decreases. After diluting the cell culture, the mitotic
activity returns. This well-known phenomenon, generally termed
``contact inhibition'', suggests that cell density may play a role in
keratinocyte function (Kulesh and Greene, 1986; Watt et al, 1988).
The cell-density-regulated keratinocyte function presumably rep-
resents a crucial regulatory mechanism during wound healing,
when the reepithelialization process and the subsequent recon-
struction of epidermis require a strong regulation in order to restore
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the original tissue structure. This physiologic mechanism operates
via inhibitory signals blocking mitotic cell division and presumably
other functions of keratinocytes at high cell densities.
In these studies we found distinct migration activities of
keratinocytes when obtained from low and high density con¯uent
cultures. We attempted to analyze the possible role of cell density in
the altered responsiveness of keratinocytes using the HaCaT cell
line. Our results show that change in the chemotactic responsive-
ness of keratinocytes toward regulated on activation and normal
T cell expressed and secreted (RANTES) directly correlates with
CC chemokine receptor 1 (CCR1) expression, but is inversely
proportional to the constitutive RANTES production. Our results
also suggest that the constitutive RANTES production by HaCaT
cells might regulate the surface expression of CCR1 via a
homologous desensitization and internalization mechanism.
MATERIALS AND METHODS
Cell culture Two 3 106 HaCaT keratinocytes in 10 ml RPMI 1640
(Gibco BRL, Grand Island, NY) with 10% fetal bovine serum
(HyClone, Logan, UT) (R10) were plated into 75 cm2 tissue culture
¯asks and cultured at 37°C with 5% CO2 for the designated periods.
Supernatants were collected every 24 h or changed with fresh R10 for
further culture. Primary human epidermal keratinocytes were purchased
from Clonetics (BioWhittaker, Walkersville, MD) and were cultured
without serum in the presence of bovine pituitary extract, human
recombinant epidermal growth factor, insulin, hydrocortisone, transferrin,
epinephrine, gentamicin, and amphotericin B, according to the
manufacturer's instructions. Third passage cultures were used for all
experiments.
Cell density determination The strongly adherent HaCaT
keratinocytes were detached by trypsin±ethylenediamine tetraacetic acid
(Sigma, St. Louis, MO), washed repeatedly, and used immediately for
experimental analysis. The cell viability was typically near 100%, as
determined by the Trypan blue exclusion, and this detachment method
resulted in a single-cell keratinocyte suspension required for the
migration assay.
Chemotactic migration The keratinocyte suspension was adjusted
to 1 3 106 per ml in binding medium [1% bovine serum albumin (BSA)
in RPMI 1640], and the chemotaxis toward interleukin 8 (IL-8),
RANTES (both were purchased from PeproTech, Rocky Hill, NJ), and
a synthetic m-opioid receptor agonist [D-ala2, N-Me-Phe4, Gly-
ol5]enkephalin (DAMGO; Multiple Peptide Systems, San Diego, CA)
was determined using 48-well microchemotaxis chambers with 12 mm
pore size uncoated polycarbonate membranes. Migration was terminated
Figure 1. Growing kinetics of HaCaT keratinocytes in vitro. The
starting HaCaT cell density was adjusted to 2.7 3 104 per cm2 in a
75 cm2 tissue culture plate, and the medium was changed daily. In such
abundant nutritional conditions HaCaT cells expressed three-phase
growing kinetics. The fast-growing logarithmic phase was typically
followed by an incomplete stationary phase starting at day 5, when the
majority of cultures showed partial multilayer formation. 100%
con¯uency developed by day 3. The cell viability during the 6 d culture
period was about 100%. The inset shows the same data in a
semilogarithmic plot, where the logarithmic phase of cell growth from
day 1 to day 4 is more evident. Each data point represents the mean 6
SD of ®ve experiments.
Figure 2. Morphologic characteristics of low
and high density HaCaT cultures. Con¯uent
low density cultures were typically composed of
fully spread keratinocytes (a, c) with some shape
variations and size variations in the entire culture.
High-power magni®cation shows extensive cell±
cell connections between adjacent keratinocytes
(c). High density cultures (b, d) tend to form
partial multilayers (d, arrowheads). Hematoxylin±
eosin staining. Scale bars: (a, b), 20 mm; (c, d),
5 mm.
1084 SZABO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
after incubation for 45 min at 37°C, and then the ®lter was removed
and the top surface of the membrane was wiped to remove nonmigrated
cells. The membrane was ®xed and stained with a Diff-Quick staining
kit. The chemotaxis was evaluated by counting the stained migrating
cells at the bottom of the membrane in four representative ®elds by light
microscopy. Chemotaxis is reported as the chemotaxis index, and
represents the percentage change compared to the migration toward
medium alone. All experiments were carried out in triplicate and
repeated at least ®ve times.
Measurement of RANTES in HaCaT supernatants The
concentration of RANTES present in culture supernatants was
determined by enzyme-linked immunosorbent assay (ELISA), using
matched mouse capture and detection antibodies in a sandwich ELISA.
Anti-chemokine ``capture'' antibody used in these experiments was
rabbit polyclonal antihuman RANTES (Pharmingen, San Diego, CA).
The capture antibody was coated onto plastic microwell plates (Nalge,
Rochester, NY) and blocked with 1% BSA-containing phosphate-
buffered saline (PBS), and graded dilutions of culture supernatant or
recombinant standard (Peprotech) were added. After washing, the
captured chemokine proteins were detected using biotin-conjugated
antichemokine ``detection'' polyclonal antihuman RANTES, followed
by horseradish peroxidase linked streptavidin (Vector Laboratories,
Burlingame, CA). Following the addition of ABTS [2,2¢-azino-bis-(3-
ethylbenzthiazoline-6-sulfonic acid)] in buffer, the level of colored
product was measured spectrophotometrically at 405 nm. No detectable
RANTES was found in the culture medium.
Evaluation of CCR1 and CCR5 expression by confocal laser
scanning microscopy Keratinocytes (105 per culture) were plated
into 24-well plates with sterile round coverslips and cultured at 37°C
and 5% CO2 for the designated culture period. In order to block the
constitutive RANTES effect, goat antihuman anti-RANTES antibody
(Sigma) was added to the cultures at a neutralizing concentration (33 ng
per ml) and this medium was changed daily. Two day and 4 d cultures,
representing the low and high density monolayers in a 75 cm2 tissue
culture ¯ask, were ®xed with 4% paraformaldehyde and analyzed for
CCR1 and CCR5 expression. In order to detect the intracellular
receptor pool, the cell membrane was permeabilized with 0.1% saponin
(Sigma) for 30 min at room temperature and the subsequent staining
procedure was performed in the continuous presence of saponin.
Nonspeci®c binding was blocked with 1% BSA-containing PBS. The
expression of CCR1 was detected using biotinylated mouse antihuman
CCR1 antibody (R&D Systems, Minneapolis, MN), and detected by
streptavidin±phycoerythrin (PE) (Sigma). For CCR5 staining, PE-labeled
mouse-antihuman CCR5 antibody (Pharmingen) was used. The
coverslips were mounted to microscope slides using the Prolong Antifade
Kit (Molecular Probes, Eugene, OR), and the samples were analyzed
using an Olympus ¯uoview confocal laser scanning microscope.
RESULTS
Growing kinetics and morphologic change of HaCaT
keratinocytes during in vitro culture HaCaT keratinocytes
were seeded into tissue culture ¯asks, so that the starting cell density
was 2.7 3 104 per cm2, and then the medium was replaced with
10 ml of fresh R10 daily. Analysis of growing kinetics of these
cultures revealed a series of three phases (Fig 1). We typically
observed a 1 d lag phase, which was followed by a logarithmic
growing phase, with a growth rate of 00.05 per h and a 20 h
duplication time. By the third day of culture a low density, but
already con¯uent, monolayer developed with fully spread
individual cells (Fig 2a, c). In the late logarithmic phase the cell
shape changed to an almost spherical or cubic type with a diameter
nearly that of the cell nucleus due to the high cell density (Fig 2b).
The third incomplete stationary phase of cell growth started at
about day 5, when, in spite of the complete liquid phase over the
monolayer, the HaCaT keratinocytes tended to form partial
multilayers (Fig 2d).
Chemotactic migration of HaCaT keratinocytes Our
previous studies showed that HaCaT keratinocytes migrate
toward several chemokines and opioids, including RANTES, IL-
8, and DAMGO. The results show (Fig 3) that optimal
chemotactic concentrations of RANTES, IL-8, and DAMGO are
0.05 nM 0.1 nM, and 0.1 nM, respectively. In these previous
studies we typically observed a weak migration response for
keratinocytes obtained from subcon¯uent monolayers, and
signi®cant differences in the chemotactic responsiveness of cells
from con¯uent monolayers with various densities. As no systematic
analysis of cell-density-induced modulation in keratinocyte
migration has been reported, we attempted to analyze the role of
cell density in the altered responsiveness. This study revealed that
HaCaT cells from the low density cultures expressed a modest level
of chemotactic migration toward RANTES, IL-8, and DAMGO
(Fig 4). Keratinocytes from the high density cultures, however,
Figure 3. Chemotaxis of HaCaT keratinocytes toward RANTES,
IL-8, and DAMGO. The chemotactic responsiveness of HaCaT cells
was determined by a microchemotaxis assay. Migration toward the
designated concentrations of chemoattractants was terminated after
45 min incubation at 37°C, and the migrating cells were then stained
and counted. Chemotaxis is reported as the chemotaxis index, and
represents the percentage change compared to the migration toward
medium alone. Each data point represents the mean 6 SEM of ®ve
experiments.
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expressed a strong chemotactic response, reaching a maximum at
around day 5. The maximum responsiveness toward DAMGO was
found on day 6 (152% of medium control), toward RANTES on
day 5 (454% of medium control), and toward IL-8 on day 6 (142%
of medium control). We found RANTES to be the most potent
chemoattractant for HaCaT keratinocytes in these experiments.
RANTES production by HaCaT keratinocytes during cell
growth Keratinocytes have been found to produce RANTES,
IL-8, and opioid peptides under both in vitro and in vivo conditions
(Wintzen et al, 1996; Engelhardt et al, 1998; Fukuoka et al, 1998;
Raychaudhuri et al, 1999; Zanello et al, 1999; Frank et al, 2000;
Mazurkiewicz et al, 2000; Rennekampff et al, 2000). We
hypothesized that these constitutively produced chemoattractants
might modulate keratinocyte responsiveness during cell growth. As
the most signi®cant change in chemotactic responsiveness was
found for RANTES, we analyzed the kinetics of chemokine
expression during the entire culture period. We found that the
production of RANTES by the low density HaCaT keratinocytes
was ®ve to six times greater than the production by high density
cells (Fig 5). The level of RANTES measured in the culture
supernatants represented the production of this chemokine in a 24 h
period, as the supernatant was replaced with fresh medium daily.
Moreover, when the RANTES production was plotted as a
function of cell density, an exponential relationship was found. The
Fig 5 data also show that keratinocytes from the high-RANTES-
producing cultures expressed a low migratory response toward
external RANTES, and that the chemotactic responsiveness
signi®cantly increased in the low-RANTES-producing high cell
density cultures.
CCR1 and CCR5 expression on HaCaT keratinocytes
during cell growth Using confocal laser scanning microscopy,
we attempted to determine whether the altered responsiveness in
migration of HaCaT keratinocytes toward RANTES was
associated with an altered expression of the receptors for this
chemokine. We studied the expression of the major RANTES
receptors CCR5 and CCR1 on adherent keratinocytes in low and
high density monolayers. We were not able to detect any speci®c
CCR5 staining of keratinocytes at any cell density (Fig 6a, b). In
contrast, keratinocytes from the high density culture showed
intense CCR1 expression (Fig 6d), whereas the CCR1-speci®c
staining of low density cells was greatly reduced (Fig 6c). The
surface expression of CCR1 was also studied on primary human
epidermal keratinocytes (Fig 6e). These cells showed intense
CCR1 staining even in a very low density culture.
Regulation of surface CCR1 expression on HaCaT keratino-
cytes In order to analyze the relationship between surface
expression of CCR1 and the intracellular receptor pool, we
carried out experiments comparing CCR1 staining of intact and
permeabilized HaCaT cells using confocal laser scanning
microscopy (Fig 7). Low density cells expressing a low level of
surface CCR1 (Fig 7a) contained a signi®cant intracellular
receptor pool (Fig 7c). High density cells, however, showed a
similar intense CCR1 staining both in intact and permeabilized
cells (Fig 7b, d). As the surface expression of CCR1 on HaCaT
keratinocytes might be regulated by the constitutive production of
RANTES via a homologous desensitization process, we carried out
Figure 4. Distinct chemotactic responsiveness of keratinocytes
from low and high density cultures. Both the chemotactic
responsiveness and the cell density of cultured HaCaT keratinocytes were
determined daily. The chemotaxis toward RANTES (0.05 nM), IL-8
(0.1 nM), and DAMGO (0.1 nM) was determined. Keratinocytes from
low density cultures expressed modest chemotactic migration; however,
keratinocytes from the high density cultures exerted strong chemotactic
response. Bars represent the mean 6 SEM of triplicate determinations.
Representative experiment of ®ve.
Figure 5. Kinetics of autocrine RANTES
production in keratinocyte cultures. Super-
natants from HaCaT keratinocyte cultures were
analyzed for RANTES production by ELISA.
Keratinocytes in low density cultures produced
signi®cantly more RANTES than did cells from
higher density cultures, resulting in an exponential
decrease in RANTES production during the
culture. Experimental data show a close
correlation with a modi®ed exponential equation
(solid line), and a reciprocal change of autocrine
RANTES production and chemotaxis toward
external RANTES (see Fig 4) is evident. Bars
represent the mean 6 SEM of triplicate
determinations. Representative experiment of ®ve.
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experiments with neutralizing antibodies against RANTES. In the
continuous presence of anti-RANTES antibodies, the difference in
the surface expression of CCR1 of low and high density cells was
greatly reduced (Fig 7e, f).
DISCUSSION
Chemokines have been found to play an important role in several
physiologic and pathophysiologic processes, including embryo-
genesis (Gupta et al, 1998; Quackenbush et al, 1998; McGrath et al,
1999; Tilton et al, 2000), immune function (Taub and Oppenheim,
1994; Ma et al, 1998; Wilkinson et al, 1999; Tilton et al, 2000),
in¯ammation (Ransohoff, 1997; Afford et al, 1998; Luster, 1998;
Lo et al, 1999; Locati and Murphy, 1999; Lukacs et al, 1999;
Murphy et al, 2000; Nansen et al, 2000), and tissue regeneration
(Wang et al, 1998; Weber et al, 1999; Murdoch and Finn, 2000).
Immunohistologic studies suggest that in¯ammatory skin diseases
and wound healing also involve chemokine-regulated cell traf®ck-
ing. In these conditions in cutaneous tissue, activated keratinocytes
represent the primary source of the chemokines responsible for
leukocyte traf®cking into the in¯ammatory site, although during
wound healing platelets also contribute to leukocyte recruitment
with releases of their chemokine content into the wound bed
(Kameyoshi et al, 1992; Gillitzer et al, 1996; Taub, 1996;
Engelhardt et al, 1998; Fukuoka et al, 1998; Goebeler et al, 1998;
Kulke et al, 1998; Faunce et al, 1999; Raychaudhuri et al, 1999;
Yawalkar et al, 1999; Devalaraja et al, 2000; Dieu-Nosjean et al,
2000; Homey et al, 2000; Jackman et al, 2000; Taha et al, 2000;
Wetzler et al, 2000). We found that the HaCaT immortalized
human keratinocyte cell line was able to manifest a chemotactic
response to RANTES and IL-8. We also found that these cells
exhibited a signi®cant response to the speci®c m-receptor agonist
DAMGO. Keratinocyte responsiveness to opioids is not completely
unexpected, and might be related to their neuroectodermal origin.
We found signi®cant differences, however, in the chemotactic
responsiveness of keratinocytes during in vitro cell growth.
Keratinocytes attached from subcon¯uent monolayers demon-
strated weak migration responses toward RANTES, IL-8, and
DAMGO. Keratinocytes from the high density culture, however,
expressed much stronger chemotactic responses, reaching a maxi-
mum by day 5 or 6. These data suggest that cell density may play a
regulatory role in keratinocyte migration in vitro. We believe that
the low and high density in vitro cultures resemble the early and late
phases of the reepithelialization process. Our hypothesis is
supported by evidence that keratinocyte function can be regulated,
in part, by the in¯uence of adjacent cell number or the pressure
generated by these adjacent cells (Kippenberger et al, 2000). These
in¯uences might lead to hyperproliferation of keratinocytes during,
for example, subcutaneous tumor growth or pregnancy in vivo.
In abundant nutritional conditions the altered keratinocyte
function might be associated with a morphologic change in the cells
Figure 6. Keratinocytes from high density
cultures show intense CCR1 expression. Low
density (a, c) and high density (b, d) HaCaT
cultures were stained with PE-labeled CCR5 (a,
b) and CCR1 (c, d) antibodies. The samples were
analyzed by confocal laser scanning microscopy.
No speci®c CCR5 staining was found (a, b);
however, high density keratinocytes showed
intense CCR1 labeling (d). Primary human
epidermal keratinocytes showed intense CCR1
staining during in vitro culture (e). Scale bar:
20 mm.
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during in vitro culture. Low density cultures are characteristically
composed of fully spread keratinocytes, whereas high density
cultures are much less spread spherical or cubic cells with a narrow
cytoplasm. Microscopic evaluation of late cultures with a low level
of mitotic activity revealed heterogeneous keratinocyte mor-
phology, as many cells seemed to escape from the monolayer,
forming partial multilayers. Keratinocytes detached from these
cultures also showed altered functional activities. As the high
migration responsiveness returns to a lower level, with dilution of
high density keratinocyte cultures allowing cells to be fully spread
again, the role of a putative mechano-sensor/receptor detecting the
mechanical pressure generated by adjacent cells cannot be ruled
out. Recent data support the concept of a mechano-receptor
function in primary human epidermal keratinocytes. Brief stretch-
ing of keratinocyte monolayers was found to activate signal
transduction cascade in cells, presumably via induction of a
morphologic change and/or a decrease in the pressure generated
by adjacent cells (Kippenberger et al, 2000).
Epidermal keratinocytes have been found to produce RANTES
in certain in vivo and in vitro conditions (Fukuoka et al, 1998;
Raychaudhuri et al, 1999; Frank et al, 2000). We found a much
higher level of constitutive RANTES production in low density
HaCaT cultures, which was dramatically decreased to a low level in
high density cultures. Our results show, moreover, that following
dilution of high density cultures the RANTES production was
signi®cantly increased. These data strongly suggest that cell density
might exert a signi®cant modulatory role on RANTES production
of HaCaT keratinocytes, with signi®cant downregulation in high
density cultures.
Experimental data indicate that chemotactic migration may be
regulated by homologous and heterologous downregulation of
chemokine receptors in continuous presence of the ligand,
Figure 7. Surface expression and intracellular
staining of CCR1 on HaCaT cells during
in vitro culture. CCR1 staining of intact (a, b)
and permeabilized (c, d) HaCaT keratinocytes
from low and high density cultures is shown.
Note the intense intracellular CCR1 staining for
low density cells (c). Low density (e) and high
density (f) HaCaT cultures maintained in the
presence of anti-RANTES neutralizing antibody
show similar expression of surface CCR1. Scale
bar: 50 mm.
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providing rapid alteration in chemoattractant responsiveness (Ali
et al, 1999). As keratinocyte migration toward RANTES was found
to be inversely proportional to the constitutive RANTES produc-
tion, we attempted to determine whether the expression of the
major RANTES receptors on HaCaT cells might follow this
pattern. We were not able to detect speci®c surface chemokine
receptor expression on HaCaT cells by ¯uorescence-activated cell
sorter analysis, presumably due to trypsinization (data not shown).
Immunostaining of surface receptors on adherent cells, however,
provided a good opportunity for such analysis. We could not detect
any speci®c CCR5 expression in either low or high density
monolayers. CCR1 staining, on the other hand, was signi®cantly
increased in high density cultures compared to low density
monolayers. In order to analyze the regulatory mechanism
responsible for surface expression of CCR1 by HaCaT cells, we
permeabilized the cell membrane and assessed the intracellular
CCR1 receptor pool. The results from these experiments show
intense CCR1 staining in permeabilized HaCaT cells from the low
density cultures, suggesting a large intracellular receptor pool, but
the surface expression was downregulated. High density cells
showed no signi®cant change. With the addition of the anti-
RANTES antibody, we believe the constitutive RANTES
production induces homologous desensitization of surface recep-
tors, and the neutralizing anti-RANTES antibody inhibits CCR1
downregulation in the low density cultures. These data provide
strong evidence of a homologous desensitization mechanism
regulating the surface CCR1 expression in HaCaT cells. Primary
human epidermal keratinocytes, on the other hand, showed intense
surface CCR1 expression during in vitro culture (even in a very low
density stage) presumably due to the lack of constitutive RANTES
production in vitro (Li et al, 1996).
The low level of chemotactic responsiveness in the low density
cultures may be explained by the constitutively produced
RANTES, or possibly other chemoattractants, which might induce
a downregulation and/or desensitization of the corresponding
surface receptor(s). We speculate that once the cells reach the high
density stage, keratinocytes decrease RANTES production, allow-
ing the cells to respond to the chemoattractant signals. This
``chemoattractant sheath'' might protect the single cells or less
organized cell groups from potentially undesirable migration during
the reepithelialization process in wound healing. Clari®cation of
the exact mechanism of the cell-density-mediated regulation and
the molecular nature of a putative mechano-receptor will require
further investigation.
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